20191022192841614.jpg
BeyondSpring Announces Five Presentations at the American Society of Clinical Oncology (ASCO) Annual Meeting
April 28, 2021 16:37 ET | BeyondSpring, Inc.
- Four presentations to focus on the clinically meaningful endpoint improvement, including the reduction of febrile neutropenia and hospitalization, shown by plinabulin in the prevention of...
HorizonBancorpInc_SM.jpg
Horizon Bancorp, Inc. Announces First Quarter 2021 Financial Results
April 28, 2021 16:35 ET | Horizon Bancorp, Inc.
MICHIGAN CITY, Ind., April 28, 2021 (GLOBE NEWSWIRE) -- (NASDAQ GS: HBNC) — Horizon Bancorp, Inc. (“Horizon” or the “Company”) announced its unaudited financial results for the three months ending...
Flowr_Corp_Final%20Logo.jpg
The Flowr Corporation Announces Fourth Quarter and Full Year 2020 Results
April 28, 2021 16:33 ET | The Flowr Corporation
TORONTO, April 28, 2021 (GLOBE NEWSWIRE) -- The Flowr Corporation (TSX.V: FLWR; OTC: FLWPF) (“Flowr” or the “Company”) herein announces its financial and operational results for the fourth quarter...
alimera-sciences-inc-logo.jpg
Alimera Sciences Announces First Quarter 2021 Financial Results
April 28, 2021 16:32 ET | Alimera Sciences, Inc.
ATLANTA, April 28, 2021 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company that specializes in the commercialization and development of prescription...
BIOSIGHT logo .png
Biosight to Present Updated Clinical Data from Ongoing Phase 2b Study of Aspacytarabine (BST-236) at the 2021 ASCO Annual Meeting
April 28, 2021 16:31 ET | BioSight Ltd.
AIRPORT CITY, Israel, April 28, 2021 (GLOBE NEWSWIRE) -- Biosight Ltd., a pharmaceutical development company developing innovative therapeutics for hematological malignancies and disorders,...
Oncocyte_Logo_Horizontal_Main.jpg
Oncocyte to Present New Data on DetermaIO™ Test as a Predictor of Immunotherapy Response in Renal Cell Cancer at the 2021 ASCO Annual Meeting
April 28, 2021 16:31 ET | Oncocyte Corporation
IRVINE, Calif., April 28, 2021 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across...
email-logo.jpg
Tenaris Announces 2021 First Quarter Results
April 28, 2021 16:30 ET | Tenaris S.A.
The financial and operational information contained in this press release is based on unaudited consolidated condensed interim financial statements presented in U.S. dollars and prepared in accordance...
email-logo.jpg
Tenaris anuncia los resultados del primer trimestre de 2021
April 28, 2021 16:30 ET | Tenaris S.A.
La información financiera y operativa incluida en este comunicado de prensa está basada en estados contables intermedios consolidados condensados no auditados presentados en dólares estadounidenses...
CHAMPION.jpg
ChampionX Reports First Quarter 2021 Results
April 28, 2021 16:30 ET | ChampionX Corporation
Revenue of $684.9 millionNet income attributable to ChampionX of $5.8 million; adjusted net income of $15.6 millionAdjusted EBITDA of $94.2 millionCash from operating activities of $90.2 million and...
Arcutis logo.png
Arcutis to Present at the 2021 Truist Securities Life Sciences Summit
April 28, 2021 16:30 ET | Arcutis Biotherapeutics, Inc.
WESTLAKE VILLAGE, Calif., April 28, 2021 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments...